Anika Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ANIK Nasdaq 2834 https://www.anikatherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anika Therapeutics Inc

Blueprint Medicines (BPMC) Up More Than 30% YTD: Here's Why - Dec 13th, 2019 2:25 pm
ProQR (PRQR) Begins Dosing in Phase I/II Eye Disorder Study - Dec 12th, 2019 8:19 pm
BioCryst Submits NDA for Hereditary Angioedema Candidate - Dec 12th, 2019 7:34 pm
Amgen's Osteoporosis Drug Evenity Gets Approval in Europe - Dec 12th, 2019 2:36 pm
Is Anika Therapeutics, Inc. (ANIK) A Good Stock To Buy ? - Dec 11th, 2019 9:11 pm
Vertex's Kalydeco Gets EU Approval to Treat CF in Infants - Dec 11th, 2019 7:42 pm
VistaGen Up on Fast Track Designation for Anxiety Disorder Drug - Dec 11th, 2019 3:06 pm
Intra-Cellular Therapies (ITCI) in Focus: Stock Moves 6.1% Higher - Dec 11th, 2019 1:40 pm
TG Therapeutics' Shares Soar on Positive Early-Stage Data - Dec 10th, 2019 2:26 pm
Anika Commences Full U.S. Commercial Launch of TACTOSET Bone Repair Therapy at Orthopaedic Summit 2019: Evolving Techniques - Dec 10th, 2019 1:30 pm
Regeneron Reports Initial Data for Multiple Myeloma Drug - Dec 9th, 2019 9:31 pm
bluebird Reports Positive Top-Line Data on Myeloma Drug - Dec 9th, 2019 9:03 pm
Alexion (ALXN) Looks Good: Stock Adds 6% in Session - Dec 9th, 2019 1:36 pm
Sage Therapeutics' Depression Drug Fails in Study, Stock Down - Dec 6th, 2019 2:26 pm
Spero Posts Preliminary Data on SPR720 for Pulmonary Disease - Dec 5th, 2019 8:53 pm
Ra Pharmaceuticals Begins Phase II Study on Autoimmune Drug - Dec 5th, 2019 3:02 pm
Zealand Initiates Second Late-Stage CHI Study on Dasiglucagon - Dec 5th, 2019 2:07 pm
Biogen's Lupus Candidate Meets Endpoint in Phase II Study - Dec 4th, 2019 3:25 pm
Seattle Genetics, Astellas Tie Up With Merck for Cancer Study - Dec 3rd, 2019 3:45 pm
Amarin's Vascepa MAA for Heart Risk Indication Accepted in EU - Dec 3rd, 2019 2:16 pm